ProBDNF promotes sepsis-associated encephalopathy in mice by dampening the immune activity of meningeal CD4+ T cells

Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Fear conditioning tests were conducted for cognitive ass...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuroinflammation Vol. 17; no. 1; pp. 169 - 17
Main Authors Luo, Ru-Yi, Luo, Cong, Zhong, Feng, Shen, Wei-Yun, Li, Hui, Hu, Zhao-Lan, Dai, Ru-Ping
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 28.05.2020
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg )-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. In the septic mice, cognitive function was impaired, the percentage of CD4 T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg ) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4 T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4 T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4 T cells in cultured splenocytes from septic mice (P = 0.0021). Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4 T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.
AbstractList Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Methods Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg−1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. Results In the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg−1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021). Conclusion Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.
Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg.sup.-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. In the septic mice, cognitive function was impaired, the percentage of CD4.sup.+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg.sup.-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4.sup.+ T cells. Intraperitoneal injection of McAb-proB (100 [mu]g) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4.sup.+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 [mu]g) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4.sup.+ T cells in cultured splenocytes from septic mice (P = 0.0021). Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4.sup.+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.
Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Methods Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg.sup.-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. Results In the septic mice, cognitive function was impaired, the percentage of CD4.sup.+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg.sup.-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4.sup.+ T cells. Intraperitoneal injection of McAb-proB (100 [mu]g) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4.sup.+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 [mu]g) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4.sup.+ T cells in cultured splenocytes from septic mice (P = 0.0021). Conclusion Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4.sup.+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis. Keywords: Sepsis, Encephalopathy, Meningeal immunity, CD4.sup.+ T cells, Brain-derived neurotrophic factor precursor, Monoclonal antibody
Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg )-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. In the septic mice, cognitive function was impaired, the percentage of CD4 T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg ) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4 T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4 T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4 T cells in cultured splenocytes from septic mice (P = 0.0021). Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4 T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.
Abstract Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE. Methods Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg−1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice. Results In the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg−1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021). Conclusion Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.
Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE.BACKGROUNDSepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate the roles of T lymphocytes, proBDNF, and their interaction in the pathogenesis of SAE.Fear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice.METHODSFear conditioning tests were conducted for cognitive assessment in the lipopolysaccharide (LPS, 5 mg kg-1)-induced septic mice. Meninges and peripheral blood were harvested for flow cytometry or qPCR. FTY720 and monoclonal anti-proBDNF antibody (McAb-proB) were used to investigate the effect of lymphocyte depletion and blocking proBDNF on the impaired cognitive functions in the septic mice.In the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021).RESULTSIn the septic mice, cognitive function was impaired, the percentage of CD4+ T cells were decreased in the meninges (P = 0.0021) and circulation (P = 0.0222), and pro-inflammatory cytokines were upregulated, but the anti-inflammatory cytokines interleukin (IL)-4 (P < 0.0001) and IL-13 (P = 0.0350) were downregulated in the meninges. Lymphocyte depletion by intragastrically treated FTY720 (1 mg kg-1) for 1 week ameliorated LPS-induced learning deficit. In addition, proBDNF was increased in the meningeal (P = 0.0042) and peripheral (P = 0.0090) CD4+ T cells. Intraperitoneal injection of McAb-proB (100 μg) before LPS treatment significantly alleviated cognitive dysfunction, inhibited the downregulation of meningeal (P = 0.0264) and peripheral (P = 0.0080) CD4+ T cells, and normalized the gene expression of cytokines in the meninges. However, intra-cerebroventricular McAb-proB injection (1 μg) did not have such effect. Finally, exogenous proBDNF downregulated the percentage of CD4+ T cells in cultured splenocytes from septic mice (P = 0.0021).Upregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.CONCLUSIONUpregulated proBDNF in immune system promoted the pathogenesis of SAE through downregulating the circulating CD4+ T cells, limiting its infiltration into the meninges and perturbing the meningeal pro-/anti-inflammatory homeostasis.
ArticleNumber 169
Audience Academic
Author Zhong, Feng
Shen, Wei-Yun
Luo, Cong
Li, Hui
Dai, Ru-Ping
Hu, Zhao-Lan
Luo, Ru-Yi
Author_xml – sequence: 1
  givenname: Ru-Yi
  surname: Luo
  fullname: Luo, Ru-Yi
– sequence: 2
  givenname: Cong
  surname: Luo
  fullname: Luo, Cong
– sequence: 3
  givenname: Feng
  surname: Zhong
  fullname: Zhong, Feng
– sequence: 4
  givenname: Wei-Yun
  surname: Shen
  fullname: Shen, Wei-Yun
– sequence: 5
  givenname: Hui
  surname: Li
  fullname: Li, Hui
– sequence: 6
  givenname: Zhao-Lan
  surname: Hu
  fullname: Hu, Zhao-Lan
– sequence: 7
  givenname: Ru-Ping
  surname: Dai
  fullname: Dai, Ru-Ping
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32466783$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNURB_wB1ggS2yQUIrfTjZIZUqhUgUsytpynJsZjxI7xJ5K8-9xZlroVAhZsiP73M851-e0OPLBQ1G8JvickEp-iITWipeY4hKTSuT5WXFCFKclxTU_evR9XJzGuMaYUSHpi-KYUS6lqthJkX5M4dPltys0TmEICSKKMEYXSxNjsM4kaBF4C-PK9GE0abVFzqPBWUDNFrVmGME7v0RpBcgNw8YDMja5O5e2KHRo2J2C6dHikr9Ht8hC38eXxfPO9BFe3a9nxc-rz7eLr-XN9y_Xi4ub0grJUikJNqRhQJkCw1RlVId5y6XohOWSNJyJFncUU2ka2hJVNaIGgSWXkJWdYGfF9Z7bBrPW4-QGM211ME7vNsK01GZKzvagucCqy7fhqjZcsroxgjUtqTMf2qZTmfVxzxo3zQCtBZ8m0x9AD0-8W-lluNOKCkU5zoB394Ap_NpATHpwcW6H8RA2UWdNNXsRPEvfPpGuw2byuVVZRbgSnAr2V7U02YDzXcj32hmqLyRVTNK6mv_7_B-qPFrIr5gD1bm8f1Dw5rHRPw4fMpMF1V5gpxDjBJ22Lpnkwuzb9ZpgPcdT7-Opczz1Lp567gF9UvpA_0_RbzBh5W0
CitedBy_id crossref_primary_10_1007_s12640_023_00655_2
crossref_primary_10_3389_fnins_2021_665757
crossref_primary_10_1007_s12035_020_02113_y
crossref_primary_10_1016_j_intimp_2023_110448
crossref_primary_10_1186_s10020_023_00621_w
crossref_primary_10_1126_sciadv_abj2797
crossref_primary_10_1096_fj_202101558R
crossref_primary_10_1016_j_clim_2024_110206
crossref_primary_10_1186_s13019_024_03038_6
crossref_primary_10_3389_fcvm_2021_747467
crossref_primary_10_1155_2022_3777351
crossref_primary_10_1136_lupus_2022_000836
crossref_primary_10_1161_JAHA_122_028198
crossref_primary_10_1016_j_cellimm_2022_104545
crossref_primary_10_1002_ibra_12055
crossref_primary_10_1155_2021_6652846
crossref_primary_10_1016_j_clim_2023_109880
crossref_primary_10_2147_JIR_S387127
crossref_primary_10_3390_jcm12134309
crossref_primary_10_1016_j_fmre_2022_10_002
crossref_primary_10_1021_acschemneuro_3c00180
crossref_primary_10_3389_fmicb_2024_1337994
crossref_primary_10_1002_adhm_202301325
crossref_primary_10_1016_j_expneurol_2023_114521
crossref_primary_10_3389_fimmu_2023_1155333
crossref_primary_10_1016_j_brainresbull_2022_09_007
crossref_primary_10_1080_14737175_2023_2250917
crossref_primary_10_1016_j_neuropharm_2022_109382
crossref_primary_10_1096_fj_202301140RR
crossref_primary_10_1016_j_expneurol_2023_114646
crossref_primary_10_1016_j_neuropharm_2024_110285
crossref_primary_10_3389_fcell_2021_691648
crossref_primary_10_3389_fmed_2023_1265398
crossref_primary_10_1016_j_intimp_2021_108332
Cites_doi 10.1096/fj.201901905RR
10.1038/npp.2016.100
10.1016/S0306-4530(03)00088-X
10.1523/JNEUROSCI.5123-04.2005
10.1007/s10753-015-0175-4
10.1016/j.bbi.2019.05.038
10.4049/jimmunol.1601546
10.1038/protex.2014.030
10.4161/viru.26083
10.1186/s40635-016-0091-4
10.1038/ncomms14919
10.1038/s41398-017-0015-4
10.1007/s00134-017-4807-z
10.1084/jem.20091419
10.1007/s12640-019-00081-3
10.1016/j.bbi.2010.01.001
10.1093/bja/aem201
10.1097/00003246-199008000-00001
10.1016/S0165-5728(98)00193-3
10.1002/glia.23553
10.1016/S0165-6147(99)01419-4
10.1038/nm.2106
10.1186/1471-2253-14-45
10.1016/j.jneuroim.2018.08.013
10.1016/j.bbi.2011.08.005
10.1186/s13054-017-1643-z
10.1016/j.bbi.2014.07.007
10.1177/1179573519840652
10.1186/s12974-020-1701-3
10.1007/s12028-009-9289-6
10.1038/srep27171
10.3389/fpsyt.2018.00776
10.1002/cyto.990140614
10.1016/j.cyto.2020.155049
10.1038/nature18626
10.1186/s12974-020-01759-8
ContentType Journal Article
Copyright COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12974-020-01850-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1742-2094
EndPage 17
ExternalDocumentID oai_doaj_org_article_4507fa1b089a4639ba53bd190f2edbf7
PMC7257240
A627362987
32466783
10_1186_s12974_020_01850_0
Genre Journal Article
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81771354 and 81471106
– fundername: National Natural Science Foundation of China
  grantid: 81873770
– fundername: ;
  grantid: 81771354 and 81471106; 81873770
GroupedDBID ---
0R~
29L
2WC
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7T5
7TK
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-610a1b3e237ea378a7f04d465f5c461b435d0f2026ab2d178b59e50646e7f0f53
IEDL.DBID 7X7
ISSN 1742-2094
IngestDate Wed Aug 27 01:31:17 EDT 2025
Thu Aug 21 14:10:06 EDT 2025
Thu Jul 10 20:02:09 EDT 2025
Fri Jul 25 03:48:00 EDT 2025
Tue Jun 17 21:25:59 EDT 2025
Tue Jun 10 20:41:39 EDT 2025
Thu Apr 03 07:09:36 EDT 2025
Tue Jul 01 02:54:32 EDT 2025
Thu Apr 24 22:53:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Sepsis
CD4+ T cells
Monoclonal antibody
Meningeal immunity
Encephalopathy
Brain-derived neurotrophic factor precursor
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-610a1b3e237ea378a7f04d465f5c461b435d0f2026ab2d178b59e50646e7f0f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2414754253?pq-origsite=%requestingapplication%
PMID 32466783
PQID 2414754253
PQPubID 55345
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_4507fa1b089a4639ba53bd190f2edbf7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7257240
proquest_miscellaneous_2408202654
proquest_journals_2414754253
gale_infotracmisc_A627362987
gale_infotracacademiconefile_A627362987
pubmed_primary_32466783
crossref_citationtrail_10_1186_s12974_020_01850_0
crossref_primary_10_1186_s12974_020_01850_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-28
PublicationDateYYYYMMDD 2020-05-28
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-28
  day: 28
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of neuroinflammation
PublicationTitleAlternate J Neuroinflammation
PublicationYear 2020
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References SL Devos (1850_CR23) 2013; 75
HK Teng (1850_CR13) 2005; 25
AJ Filiano (1850_CR39) 2016; 535
1850_CR24
CHARLES L. SPRUNG (1850_CR4) 1990; 18
N Quan (1850_CR11) 1999; 93
N Derecki (1850_CR20) 2014
R Sonneville (1850_CR2) 2017; 43
O Piazza (1850_CR1) 2007; 99
F Zhong (1850_CR19) 2018; 9
1850_CR6
1850_CR7
H Schweighöfer (1850_CR8) 2016; 4
TM Brombacher (1850_CR12) 2017; 198
YY Bai (1850_CR18) 2016; 41
EA Said (1850_CR36) 2010; 16
A Louveau (1850_CR25) 2015
D Kranjac (1850_CR33) 2012; 26
MP Fink (1850_CR32) 2014; 5
NC Derecki (1850_CR10) 2010; 207
DC Nascimento (1850_CR31) 2017; 8
CA Thomson (1850_CR35) 2020; 17
I Wong (1850_CR38) 2010; 24
J Trivedi (1850_CR34) 2020; 129
FS Taccone (1850_CR5) 2010; 12
HP Düsedau (1850_CR14) 2019; 67
JK Nicholson (1850_CR22) 1993; 14
V Brinkmann (1850_CR27) 2000; 21
DC Nwafor (1850_CR28) 2019; 11
C Pierrakos (1850_CR3) 2014; 14
Z Wang (1850_CR16) 2019; 36
WY Shen (1850_CR21) 2020; 34
R Gao (1850_CR17) 2015; 38
M Satomoto (1850_CR26) 2017; 17
C Ren (1850_CR9) 2020; 17
C Luo (1850_CR15) 2016; 6
XE Xu (1850_CR29) 2019; 80
ST Anderson (1850_CR30) 2015; 43
L Zhou (1850_CR37) 2018; 7
References_xml – volume: 34
  start-page: 2541
  year: 2020
  ident: 1850_CR21
  publication-title: FASEB J
  doi: 10.1096/fj.201901905RR
– volume: 41
  start-page: 2882
  issue: 12
  year: 2016
  ident: 1850_CR18
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2016.100
– volume: 75
  year: 2013
  ident: 1850_CR23
  publication-title: J Vis Exp
– volume-title: Kipnis J
  year: 2015
  ident: 1850_CR25
– ident: 1850_CR24
  doi: 10.1016/S0306-4530(03)00088-X
– volume: 25
  start-page: 5455
  issue: 22
  year: 2005
  ident: 1850_CR13
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5123-04.2005
– volume: 38
  start-page: 1949
  issue: 5
  year: 2015
  ident: 1850_CR17
  publication-title: Inflammation
  doi: 10.1007/s10753-015-0175-4
– volume: 80
  start-page: 859
  year: 2019
  ident: 1850_CR29
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2019.05.038
– volume: 17
  start-page: 192
  year: 2017
  ident: 1850_CR26
  publication-title: Exp Anim
– volume: 198
  start-page: 2681
  issue: 7
  year: 2017
  ident: 1850_CR12
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1601546
– volume-title: Mouse meninges isolation for FACS
  year: 2014
  ident: 1850_CR20
  doi: 10.1038/protex.2014.030
– volume: 5
  start-page: 143
  issue: 1
  year: 2014
  ident: 1850_CR32
  publication-title: Virulence
  doi: 10.4161/viru.26083
– volume: 4
  start-page: 19
  issue: 1
  year: 2016
  ident: 1850_CR8
  publication-title: Intensive Care Med Exp
  doi: 10.1186/s40635-016-0091-4
– volume: 8
  start-page: 14919
  issue: 1
  year: 2017
  ident: 1850_CR31
  publication-title: Nat Commun
  doi: 10.1038/ncomms14919
– volume: 7
  start-page: 1
  issue: 11
  year: 2018
  ident: 1850_CR37
  publication-title: Transl Psychiatry
  doi: 10.1038/s41398-017-0015-4
– volume: 43
  start-page: 1
  issue: 8
  year: 2017
  ident: 1850_CR2
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-017-4807-z
– volume: 207
  start-page: 1067
  issue: 5
  year: 2010
  ident: 1850_CR10
  publication-title: J Exp Med
  doi: 10.1084/jem.20091419
– volume: 36
  start-page: 540
  issue: 3
  year: 2019
  ident: 1850_CR16
  publication-title: Neurotox Res
  doi: 10.1007/s12640-019-00081-3
– volume: 24
  start-page: 585
  issue: 4
  year: 2010
  ident: 1850_CR38
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2010.01.001
– volume: 99
  start-page: 518
  issue: 4
  year: 2007
  ident: 1850_CR1
  publication-title: Br J Anaesth
  doi: 10.1093/bja/aem201
– volume: 18
  start-page: 801
  issue: 8
  year: 1990
  ident: 1850_CR4
  publication-title: Critical Care Medicine
  doi: 10.1097/00003246-199008000-00001
– volume: 93
  start-page: 72
  issue: 1-2
  year: 1999
  ident: 1850_CR11
  publication-title: J Neuroimmunol
  doi: 10.1016/S0165-5728(98)00193-3
– volume: 67
  start-page: 193
  issue: 1
  year: 2019
  ident: 1850_CR14
  publication-title: Glia
  doi: 10.1002/glia.23553
– volume: 21
  start-page: 49
  issue: 2
  year: 2000
  ident: 1850_CR27
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/S0165-6147(99)01419-4
– volume: 16
  start-page: 452
  issue: 4
  year: 2010
  ident: 1850_CR36
  publication-title: Nat Med
  doi: 10.1038/nm.2106
– volume: 14
  start-page: 45
  issue: 1
  year: 2014
  ident: 1850_CR3
  publication-title: BMC Anesthesiol
  doi: 10.1186/1471-2253-14-45
– ident: 1850_CR6
  doi: 10.1016/j.jneuroim.2018.08.013
– volume: 26
  start-page: 109
  issue: 1
  year: 2012
  ident: 1850_CR33
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2011.08.005
– ident: 1850_CR7
  doi: 10.1186/s13054-017-1643-z
– volume: 43
  start-page: 98
  year: 2015
  ident: 1850_CR30
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2014.07.007
– volume: 11
  start-page: 117957351984065
  year: 2019
  ident: 1850_CR28
  publication-title: J Central Nerv Syst Disease
  doi: 10.1177/1179573519840652
– volume: 17
  start-page: 1
  issue: 1
  year: 2020
  ident: 1850_CR9
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-020-1701-3
– volume: 12
  start-page: 35
  issue: 1
  year: 2010
  ident: 1850_CR5
  publication-title: Neurocrit Care
  doi: 10.1007/s12028-009-9289-6
– volume: 6
  start-page: 27171
  issue: 1
  year: 2016
  ident: 1850_CR15
  publication-title: Sci Rep
  doi: 10.1038/srep27171
– volume: 9
  start-page: 776
  year: 2018
  ident: 1850_CR19
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2018.00776
– volume: 14
  start-page: 685
  issue: 6
  year: 1993
  ident: 1850_CR22
  publication-title: Cytometry
  doi: 10.1002/cyto.990140614
– volume: 129
  start-page: 155049
  year: 2020
  ident: 1850_CR34
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2020.155049
– volume: 535
  start-page: 425
  issue: 7612
  year: 2016
  ident: 1850_CR39
  publication-title: Nature
  doi: 10.1038/nature18626
– volume: 17
  start-page: 94
  issue: 1
  year: 2020
  ident: 1850_CR35
  publication-title: J Neuroinflammation
  doi: 10.1186/s12974-020-01759-8
SSID ssj0032562
Score 2.4510965
Snippet Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to investigate...
Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study aimed to...
Abstract Background Sepsis-associated encephalopathy (SAE) increases the mortality of septic patients, but its mechanism remains unclear. The present study...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 169
SubjectTerms Animals
Antibodies
Brain
Brain-derived neurotrophic factor
Brain-Derived Neurotrophic Factor - immunology
Brain-Derived Neurotrophic Factor - metabolism
Brain-derived neurotrophic factor precursor
CD4 antigen
CD4 lymphocytes
CD4+ T cells
CD4-Positive T-Lymphocytes - immunology
Cognitive ability
Complications and side effects
Development and progression
Encephalopathy
Fear conditioning
Flow cytometry
FTY720
Gene expression
Health aspects
Homeostasis
Immune response
Immune system
Inflammation
Injection
Interleukin 13
Laboratory animals
Lipopolysaccharides
Lipopolysaccharides - toxicity
Lymphocytes
Lymphocytes T
Male
Memory
Meningeal immunity
Meninges
Meninges - immunology
Mice
Mice, Inbred C57BL
Monoclonal antibodies
Monoclonal antibody
Mortality
Nervous system
Noise
Pathogenesis
Peripheral blood
Physiological aspects
Protein Precursors - immunology
Protein Precursors - metabolism
Sepsis
Sepsis-Associated Encephalopathy - chemically induced
Sepsis-Associated Encephalopathy - immunology
Sepsis-Associated Encephalopathy - metabolism
Splenocytes
Studies
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JLadOX26SoUOghmNiyHvYxjy6hkNBDArmJkSyRhdRe4s0h_74zsndZU2gvvfhgjYw1D803tmaGsa9VE3REqEqVH2UunXN5A43HmKfw0fsowVOi8OWVvriRP27V7U6rLzoTNpYHHhl3LBGwRChdUTcg0Z06UJVr0Y1FEVoXUx45-rxNMDXuwRU6crFJkan18YBezcicQqUCHRReZ24oVev_c0_ecUrzA5M7Hmjxir2coCM_GV_5NXsWun32_HL6Of6GrX8-9KfnVwu-SkfswsCHsBqWQw6TCELLyY5Xd3DfUyfiJ77sOLWj5-6Jt4AAmj6ScISEfElpI4FT1gM1l-B95L_SKOJKfnYuj_g1p2_-w1t2s_h-fXaRT00Vcq90tcZQsUBuVkFUJkBlajCxkK3UKiovdekQPrXIWwzNwIm2NLVTTaCqdjogZVTVO7bX9V34wLjQrmlF7ZU3IKNRoAx4KAPIEKCQJmPlhsfWTxXHqfHFvU2RR63tKBeLcrFJLrbI2NF2zmqst_FX6lMS3ZaSamWnG6hBdtIg-y8Nytg3Erwli8bX8zAlJuAiqTaWPdEI8bRoaqQ8mFGiJfr58EZ17LQTDBYRkqQuw6rK2JftMM2k021d6B-JhoCY0Epm7P2oadslIeDVCChwtpnp4GzN85FueZfqhBvcjvHRH_8Hkz6xFyKZj8pFfcD21g-P4RDh2Np9Tpb3Gy3sMXQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBddB2MvY9_L1g0NBnso3mxZH_bDGP1YKIOUPTTQNyHJUhvI7CxOYfnvd6fYpmalL3mITkHy3fl-F-nuR8invPQyAFTFzo884dbapDSlg5wndcG5wI3DQuHZuTyb85-X4nKP9HRH3QNs70ztkE9qvl5--ftn-x0c_lt0-EJ-bSFmKZ5gIpRC-IHPB-QhRCaFjAYzPpwq5BDeWV84c-e8UXCKPfz_f1PfClXja5S34tL0KXnSAUp6tLOAZ2TP18_Jo1l3ZP6CbH6tm-PT8yldxYt3vqWtX7WLNjGdYnxF0btX12bZID_xli5qiiT11G5pZQBW418nFIAiXWAxiadYC4GUE7QJ9HccBbRJT075Ib2geBLQviTz6Y-Lk7Oko1pInJD5BhLI1GQ29yxX3uSqMCqkvOJSBOG4zCyAqioNDBI2Y1mVqcKK0mOvO-lBMoj8Fdmvm9q_IZRJW1ascMIpw4MSRijjTOYN996kXE1I1j9j7bo-5EiHsdQxHymk3ulFg1501ItOJ-RwmLPadeG4V_oYVTdIYgft-EWzvtKdQ2oOQDjAntOiNBxgmjUitxXAo8B8ZQMs8zMqXqPlwfKc6coVYJPYMUsfSQB-kpUFSB6MJME_3Xi4Nx3dm7cG6-TIPSzyCfk4DONMvPNW--YGZRCeMSn4hLzeWdqwJYDBEmAGzFYjGxzteTxSL65j93AFL2n46bf3L-sdecyiY4iEFQdkf7O-8e8Bfm3sh-hT_wDpCyum
  priority: 102
  providerName: Scholars Portal
Title ProBDNF promotes sepsis-associated encephalopathy in mice by dampening the immune activity of meningeal CD4+ T cells
URI https://www.ncbi.nlm.nih.gov/pubmed/32466783
https://www.proquest.com/docview/2414754253
https://www.proquest.com/docview/2408202654
https://pubmed.ncbi.nlm.nih.gov/PMC7257240
https://doaj.org/article/4507fa1b089a4639ba53bd190f2edbf7
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbC2MvY99L1wUNBnsopo6sD_tpNG1DGSSU0ULehCRLa6Czszh96H_fO0XJagZ98UN0CpLvTve7s-6OkG9F5WUAqIqVH3nGrbVZZSoHPk_ugnOBG4eJwtOZvLjmP-dingJuXbpWuT0T40Fdtw5j5MdgaTh2axXFj-XfDLtG4dfV1ELjOdnH0mUo1Wq-c7gKMOdsmyhTyuMObJviGTpMOZgpePaMUazZ___J_Mg09a9NPrJDk9fkVQKQ9GTD8TfkmW_ekhfT9In8HVlfrtrx2WxCl_Gine9o55fdostMYoSvKWrz8sbcttiP-J4uGopN6am9p7UBGI2hEgrAkC4wecRTzH3AFhO0DfRPHAV0SU_P-BG9ohj5796T68n51elFllorZE7IYg0OY25GtvCsUN4UqjQq5LzmUgThuBxZAFF1Hhg4aMayeqRKKyqPte2kB8ogig9kr2kb_4lQJm1Vs9IJpwwPShihjDMjb7j3JudqQEbbd6xdqjuO7S9udfQ_Sqk3fNHAFx35ovMBOdrNWW6qbjxJPUbW7SixYnb8oV391kkBNQfgG2DPeVkZDrDMGlHYGuBQYL62AZb5HRmvUa9hec6k9ATYJFbI0icSgJ5kVQmUhz1K0EfXH96Kjk7nQaf_Se-AfN0N40y849b49g5pEI4xKfiAfNxI2m5LAHslwAqYrXoy2Ntzf6RZ3MRq4QoOZfjrg6eX9Zm8ZFExRMbKQ7K3Xt35LwC31nYYdWpI9sfns8tfwxi0gOeUlw_doCvp
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLemIQEXxPcKA4wE4jBFSx1_JAeEtpWqY2vFoZN2M7Zjs0pbUppOqP8UfyPvpUlZhLTbLj3Ez5Wd9_V7sd97hHxIMi8DQFWs_Mgjbq2NMpM5iHliF5wL3DhMFB5P5OiMfzsX51vkT5sLg9cqW5tYG-q8dPiNfB88DcdurSL5Mv8VYdcoPF1tW2isxeLEr35DyFZ9Ph4Afz8yNvw6PRpFTVeByAmZLCFWik3fJp4lyptEpUaFmOdciiAcl30L-CGPA4PYxFiW91VqReaxrJv0QBmwSwSY_HvgeGMM9tT5JsBLAD6wNjEnlfsV-FLFIwzQYnCL8NtxfnWPgP89wQ1X2L2mecPvDR-TRw1gpQdrCXtCtnzxlNwfN0fyz8jy-6I8HEyGdF5f7PMVrfy8mlWRaRjvc4rWY35hLkvsf7yis4JegX2idkVzA7AdP81QAKJ0hskqnmKuBba0oGWgV_UooFl6NOB7dErxpKF6Ts7u5KW_INtFWfgdQpm0Wc5SJ5wyPChhhDLO9L3h3puYqx7pt-9Yu6bOObbbuNR1vJNKveaLBr7omi867pG9zZz5usrHrdSHyLoNJVborh-Ui5-6UXjNAWgH2HOcZoYDDLRGJDYH-BWYz22AZX5Cxmu0I7A8Z5p0CNgkVuTSBxKApWRZCpS7HUrQf9cdbkVHN_an0v-0pUfeb4ZxJt6pK3x5jTQI_5gUvEderiVtsyWA2RJgDMxWHRns7Lk7Uswu6urkCpwA_PWr25f1jjwYTcen-vR4cvKaPGS1koiIpbtke7m49m8A6i3t21q_KPlx1wr9F7mrY-c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ProBDNF+promotes+sepsis-associated+encephalopathy+in+mice+by+dampening+the+immune+activity+of+meningeal+CD4%2B+T+cells&rft.jtitle=Journal+of+neuroinflammation&rft.au=Ru-Yi+Luo&rft.au=Luo%2C+Cong&rft.au=Zhong%2C+Feng&rft.au=Wei-Yun%2C+Shen&rft.date=2020-05-28&rft.pub=BioMed+Central&rft.eissn=1742-2094&rft.volume=17&rft.spage=1&rft_id=info:doi/10.1186%2Fs12974-020-01850-0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon